Julia has been part of the teams advising:
- Black Knight, Inc. in its acquisition of Optimal Blue LLC, in a transaction that implied an enterprise value of $1.8 billion and subsequently a Special Committee of Black Knight in the $1.2 billion acquisition of all of the equity interests Black Knight did not already own in Optimal Blue
- Sanofi in its $1.9 billion acquisition of Kadmon Holdings, Inc. and its approximately $2.2 billion pending acquisition of Inhibrx, Inc.
- TPG Pace Solutions Corp., a SPAC sponsored by TPG Pace Group, in its $4.5 billion business combination with Vacasa LLC
Julia joined Weil as a summer associate in 2020. While in law school, she served as a judicial intern to the Honorable Sidney H. Stein of the U.S. District Court for the Southern District of New York.
Julia received her J.D., cum laude, from the University of Michigan Law School, where she served as the Editor-in-Chief of the Michigan Business & Entrepreneurial Law Review, and her B.A., with distinction and Phi Beta Kappa, from Cornell University. She is a native Mandarin speaker.